Sun damage predisposes pediatric patients to melanoma
the ONA take:
According to new research published in the Journal of Investigational Dermatology, researchers from the St. Jude Children's Research Hospital-Washington University Pediatric Cancer Genome Project have found that melanoma in some adolescent and adult patients involve many of the same genetic mutations and would likely respond to the same treatment.
For the study, researchers included 23 patients ranging in age from 9 months of 19 years old with melanoma. Researchers sequenced each person's genome and found that among the 15 patients with conventional melanoma, their tumors included various genetic mutations that were mostly consistent with ultraviolet light damage.
"We were surprised to see that so many of the pediatric melanomas had genetic changes linked to UV damage," said Richard K. Wilson, Ph.D., director of The Genome Institute at Washington University School of Medicine in St. Louis.
"This in-depth look at the genomics of pediatric melanoma is extraordinarily important for diagnosis and for selecting treatments that give young patients the best chances of a cure."
Melanoma in some adolescent and adult patients involve many of the same genetic mutations and would likely respond to the same treatment.
- More Than Half of Melanomas Are Self-Detected, Especially by Women
- Childhood Cancer Linked to Poor Diet Quality in Adult Survivors
- POLST Programs Can Benefit from the Relationship Between Patients and Nurse Practitioners
- Immune Checkpoint-Related Neurotoxicity May Be More Common During Combination Treatment
- Olaratumab in Combo With Doxorubicin Approved for Soft Tissue Sarcoma
- Overall Benefits of Vaporized Nicotine Products Outweigh Harms, Says International Panel of Experts
- Nurse Residency Programs Can Impact Oncology Nursing Practice, Outcomes
- Implementing a Distress Screening Process for Cancer Patients
- Initiating Palliative Care in the Emergency Department
- Exercise is as Effective in Treating Metastatic Prostate Cancer as Medication
- Caregiver Mastery Linked to Patient Survival in Glioblastoma
- Treatment Facility Volume Associated With Mortality Risk in Multiple Myeloma
- Role of regorafenib as second-line therapy and landscape of investigational treatment options in advanced hepatocellular carcinoma
- Adherence to Tamoxifen, AIs Among Older Women is Low, Study Shows
- Replacing Neoadjuvant CRT with Multiagent Chemo Not Recommended for Rectal Cancer
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|